Location

Please check the individual session for location or broadcast availability.  

Frequency

Weekly

Series Director

Andrew T. Huang, MD

Series Co-Director

N. Eddie Liou, MD

Target Audience

This activity is intended for head and neck surgical oncologists, medical oncologists, radiation oncologists, neuroradiologists, head and neck pathologists, and speech therapists outside of major tertiary referral centers.

Needs Assessment

Clinicians managing head and neck malignancies, particularly those who practice outside major tertiary referral centers, require regular, structured updates on evolving diagnostic strategies, treatment modalities, and multidisciplinary care approaches. Complex cases will serve as an impetus to review current standards of care, explore state-of-the-art treatment modalities, multidisciplinary care, and complications that affect treatment outcomes. Emphasis will be placed on enhancing collaborative decision-making, improving referral pathways and treatment timelines, and applying evidence-based guidelines. Additionally, participants will develop competencies for utilizing quality performance indicators to drive measurable improvements in patient care.

Educational Methods

Educational methods will include case presentations.

Objectives

At the conclusion of the sessions, the participants should be able to:

• Evaluate appropriate diagnostic studies, including imaging, pathology, and molecular profiling, to support accurate staging and treatment planning for patients with head and neck cancer.
• Implement individualized, evidence-based treatment plans that may include surgical therapies, systemic therapies, radiotherapy, participation in clinical trials, or other interventions tailored to each patient’s head and neck cancer disease characteristics and overall condition.
• Identify common and complex complications that may arise during or after head and neck cancer therapy.
• Apply coordinated, multidisciplinary treatment strategies to optimize functional and quality-of-life outcomes for patients following head and neck cancer therapies.

Evaluation

Participants may be asked to complete a session evaluation.

Accreditation/Credit Designation

Baylor College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baylor College of Medicine designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Series Coordinator